Role of Femoral Vein Wall Thickness and Inflammatory Markers in Patients With Behcet Disease (NCT06721234) | Clinical Trial Compass
RecruitingNot Applicable
Role of Femoral Vein Wall Thickness and Inflammatory Markers in Patients With Behcet Disease
Egypt100 participantsStarted 2024-12-02
Plain-language summary
Evaluation of femoral vein wall thickness and inflammatory indices in patients with Behcet disease and assessment of their relation to the disease activity and related some clinical manifestations
Who can participate
Age range19 Years – 80 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients fulfill the International Criteria for Behcet's Disease (ICBD)
* Age above 18 years old
* Patients cooperative and can answer questions
* Patients who are able and willing to give informed consent
Exclusion Criteria:
* Other rheumatological and vascular diseases
* Patients with abnormal hepatic or renal function tests , hyperlipidemia and impaired coagulation tests
* Patients with hypertension , diabetes mellitus , malignant and active infectious diseases
* Patients who are using aspirin and other platelet active drygs during the previous 6 months
* patients who are not able and willing to give written consent